abstract |
The present invention provides compositions and methods for treating diseases using aptamers having 5'-5 'and 3'-3' inverted nucleotide capped ends. In particular, the present invention provides 5'-5 'and 3'-3' capped VEGF aptamers for the treatment of angiogenesis related diseases and disorders including age-related macular degeneration. |